These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17468175)

  • 1. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Fu W; Shen J; Luo X; Zhu W; Cheng J; Yu K; Briggs JM; Jin G; Chen K; Jiang H
    Biophys J; 2007 Sep; 93(5):1431-41. PubMed ID: 17468175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into the D1R agonist and D2R/D3R antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Li B; Li W; Du P; Yu KQ; Fu W
    J Phys Chem B; 2012 Jul; 116(28):8121-30. PubMed ID: 22702398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats.
    Yue K; Ma B; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C
    Neuroreport; 2014 Jan; 25(1):7-11. PubMed ID: 24145772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-stepholidine, a natural dopamine receptor D1 agonist and D2 antagonist, inhibits heroin-induced reinstatement.
    Ma B; Yue K; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C
    Neurosci Lett; 2014 Jan; 559():67-71. PubMed ID: 24269875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats.
    Guo X; Ding YM; Hu JY; Jin GZ
    Life Sci; 1998; 62(25):2295-302. PubMed ID: 9651118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional reversal of (-)-Stepholidine analogues by replacement of benzazepine substructure using the ring-expansion strategy.
    Li W; Zhang L; Xu L; Yuan C; Du P; Chen J; Zhen X; Fu W
    Chem Biol Drug Des; 2016 Oct; 88(4):599-607. PubMed ID: 27232055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
    Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
    Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of (-)-stepholidine and D1 or D2 agonists on unit firing of globus pallidus in 6-hydroxydopamine-lesioned rats.
    Zhang XX; Zhu ZT; Jin GZ
    Life Sci; 1998; 63(7):537-44. PubMed ID: 9718079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with (-)-stepholidine alters density and turnover of D1 and D2 receptors in striatum.
    Zou LL; Cai ST; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):485-9. PubMed ID: 9863137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of (-)stepholidine in animal models for schizophrenia.
    Ellenbroek BA; Zhang XX; Jin GZ
    Acta Pharmacol Sin; 2006 Sep; 27(9):1111-8. PubMed ID: 16923330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors.
    Tang Y; Chen KX; Jiang HL; Jin GZ; Ji RY
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):8-12. PubMed ID: 8737443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum.
    Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ
    Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of (-)-stepholidine on the firing activity of substantia nigral dopamine neurons after repeated reserpine treatment.
    Sun BC; Jin GZ
    Biol Signals; 1992; 1(6):331-8. PubMed ID: 1307933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats.
    Hicks C; Huang P; Ramos L; Nayak SU; Caro Y; Reitz AB; Smith GR; Lee DY; Rawls SM; Liu-Chen LY
    ACS Chem Neurosci; 2018 Jun; 9(6):1327-1337. PubMed ID: 29597343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological study on biphasic firing activity elicited by D(1) agonistic-D(2) antagonistic action of (-)-stepholidine in nucleus accumbens.
    Zhu ZT; Fu Y; Hu GY; Jin GZ
    Sheng Li Xue Bao; 2000 Apr; 52(2):123-30. PubMed ID: 11961581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
    Dong ZJ; Chen LJ; Jin GZ; Creese I
    Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
    Ge H; Zhang Y; Yang Z; Qiang K; Chen C; Sun L; Chen M; Zhang J
    Bioorg Med Chem; 2019 May; 27(10):2100-2111. PubMed ID: 30981605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. l-Stepholidine increases the frequency of sEPSC via the activation of D1 dopamine signaling pathway in rat prelimbic cortical neurons.
    Gao M; Liu CL; Yang S; Zhen XC; Jin GZ
    Acta Pharmacol Sin; 2007 May; 28(5):627-33. PubMed ID: 17439718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.